Unión Europea - español - EMA (European Medicines Agency)

merz pharmaceuticals gmbh   - clorhidrato de memantina - enfermedad de alzheimer - otras drogas contra la demencia - tratamiento de pacientes con enfermedad de alzheimer de moderada a grave.

Unión Europea - español - EMA (European Medicines Agency)

mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, tipo 2 - drogas usadas en diabetes - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 y 5. 1 para datos disponibles sobre diferentes combinaciones).

Unión Europea - español - EMA (European Medicines Agency)

sun pharmaceutical industries europe b.v. - sitagliptin fumarate, metformin hydrochloride - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride sun is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride sun is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. sitagliptin/metformin hydrochloride sun is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. sitagliptin/metformin hydrochloride sun is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

Unión Europea - español - EMA (European Medicines Agency)

accord healthcare s.l.u. - metformin hydrochloride, sitagliptin hydrochloride monohydrate - diabetes mellitus, tipo 2 - drogas usadas en diabetes - for adult patients with type 2 diabetes mellitus:it is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. it is indicated in combination with a sulphonylurea (i. , terapia de combinación triple) como complemento a la dieta y ejercicio en pacientes inadecuadamente controlados en su máxima dosis tolerada de metformina y una sulfonilurea. it is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparγ) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist. it is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

industria quimica y farmaceutica vir s.a. - memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro - comprimido recubierto con pelÍcula - 5 mg + 10 mg + 15 mg + 20 mg - memantina hidrocloruro 5 mg; memantina hidrocloruro 10 mg; memantina hidrocloruro 15 mg; memantina hidrocloruro 20 mg - memantina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

laboratorio stada s.l. - memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro - comprimido recubierto con pelÍcula - 5 mg + 10 mg + 15 mg + 20 mg - memantina hidrocloruro 5 mg; memantina hidrocloruro 15 mg; memantina hidrocloruro 20 mg; memantina hidrocloruro 10 mg - memantina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

tecnimede españa industria farmaceutica, s.a. - memantina hidrocloruro, memantina hidrocloruro, memantina hidrocloruro, memantina hidrocloruro - excipientes: croscarmelosa sodica,croscarmelosa sodica,croscarmelosa sodica,croscarmelosa sodica - fÁrmacos anti-demencia - otros fármacos anti-demencia - memantina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

teva pharma s.l.u. - memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro - comprimido recubierto con pelÍcula - 5 mg + 10 mg + 15 mg + 20 mg - memantina hidrocloruro 15 mg; memantina hidrocloruro 20 mg; memantina hidrocloruro 5 mg; memantina hidrocloruro 10 mg - memantina

España - español - AEMPS (Agencia Española de Medicamentos y Productos Sanitarios)

aristo pharma iberia s.l. - memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro; memantina hidrocloruro - comprimido recubierto con pelÍcula - 5 mg + 10 mg + 15 mg + 20 mg - memantina hidrocloruro 5 mg; memantina hidrocloruro 10 mg; memantina hidrocloruro 15 mg; memantina hidrocloruro 20 mg - memantina